|
|
|
|
|
| |
Current
Issues - Newsletter
October 2002 |
|
| |
|
|
| |
|
|
| |
New Supercritical
Extraction Facility |
|
| |
| |
Sabinsa
Corporation, announced the completion of its new
supercritical carbon dioxide extraction facility
at Bangalore, India based SAMI Labs, the company’s
manufacturing division. According to Dr. Majeed,
"this facility will provide additional opportunities
for us to serve our customers better." The
capacity of the plant is about 2000 kg feed material
per day. Supercritical extraction is a two step
process which uses a dense gas, carbon dioxide
(CO2), as a solvent
above its critical temperature (31°C) and
critical pressure (74 Bar). |
|
| As the extraction
takes place at low temperatures in an inert solvent,
the color, flavor and biological value of temperature
sensitive materials remain unaffected. |
Pulverized raw material is loaded into the extractor.
Supercritical CO2 is fed to
the extractor through a high pressure pump and functions
as a solvent The extract-laden CO2
is then sent to a reduced pressure separator, where
the extract separates.
A major advantage of supercritical extraction technology
is that residual solvents are eliminated from the final
product. This is of particular importance for botanical
extracts and solvent based products. Of equal importance
is the absence of heavy metals, since they are not extractable
using this method even if they are present in the starting
material. Supercritical extraction also significantly
reduces the bio-burden, or microbial load, due to the
pressurized use of carbon dioxide.
|
|
|
| |
|
|
| |
Now Water Soluble |
|
| |
| |
Sabinsa
Corporation announces availability of a new form of its
award winning lean body mass promoting ingredient ForsLean®
Water Soluble (WS), which greatly expands dosage form
delivery options.
ForsLean® is a proprietary ingredient that has
been patented for its use in promoting lean body mass.
Coleus forskohlii’s weight management properties
are not a traditional usage of the herb from which it
is derived, and were discovered by Sabinsa. Sabinsa
was granted US Patent # 5,804,596 for its use and composition
in promotion of lean body mass, reduction of adipose
tissue (fat) and weight loss. The dietary supplements
containing ForsLean® WS will have it listed by name
on the label.
ForsLean® is a registered trademark of the Sabinsa
Corporation According to Mark C. Sysler, Sr. Executive
V.P. Marketing & Sales, the material is generating
increasing interest in manufacturing circles. The Hollywood
Celebrity Diet group has come out with "Slender
Water" using Sabinsa’s Forslean® WS and
Citrin K®. Slender Water was also handed out at
the Cannes Film Festival in France, this May.
ForsLean® shifts the proportion between lean body
mass and adipose or fatty tissue in favor of lean body
mass, thereby improving general health. The effect can
be measured by decreases in the waist hip ratio and
the body mass index.
For more information please check the the ForsLean®
websites:
www.forslean.com
www.forslean.net
Contact
Sabinsa
New Jersey office
(1-732-777-1111)
Utah office
(1-801-465-8400).
|
|
|
|
|
|
| |
Sabinsa
News
Sabinsa Corporation: In tune with the Biotech Century |
|
| |
| |
Sabinsa
Corporation entered the biotechnological age with
the inception of a production facility at Nelamangala,
near Bangalore. The first biotechnology/fermentation
products to be manufactured at this facility were
probiotics. Several new products are in the research
pipeline at the Biotech R&D facility at Nelamangala.
These facilities are geared toward quality biotechnological
products that find diverse applications in the
nutritional, pharmaceutical, food and chemical
industries. |
|
|
|
|
|
|
|
| |
Sabinsa
develops new patent-pending process for African sleeping sickness
drug |
|
| |
| |
Dr.
N. Kalyanam., President R & D along with his research
group at Sabinsa’s Princeton R & D lab, developed
a simplified cost effective and affordable manufacturing
process for eflornithine, a drug used to fight African
sleeping sickness.
Sabinsa Corporation is working in collaboration with
the WHO on this project, contributing to the organization’s
efforts to combat the parasitic disease that has resurged
in epidemic proportions in certain parts of Africa.
A patent application for this process was recently
submitted to the United States Patent and Trademark
Office.
|
|
|
|
|
|
| |
Gugulipid®
: Patent issued for Chemopreventive and Anti-inflammatory roles
|
|
| |
| |
US
Patent 6,436,991 dated August 20, 2002, granted to Sabinsa
Corporation, covers the antioxidant and cancer chemopreventive
roles of constituents of Gugulipid®, the Commiphora
mukul extract composition from Sabinsa Corporation.
This invention, titled "Compositions for prevention
and treatment of abnormal cell growth and proliferation
in inflammation, neoplasia and cardiovascular disease",
further unravels the multifaceted healthful benefits
of this increasingly popular phytonutrient.
|
|
|
|
|
|
| |
People
Focus |
|
| |
| |
Janet
Janet Thide is part of the Customer Service group
at Sabinsa Corporation, Piscataway, NJ.
A native Texan, Janet earned her Bachelor of
Business Administration
in Marketing, from Lamar University in Texas.
Janet’s background is in the Financial Printing
industry, Customer Service and Billing.
|
|
 |
Ashmed
Barrie
Ashmed Barrie Accounts Receivable Manager was recently
promoted to Director of Logistics at Sabinsa Corporation.
His responsibilities include overseeing the daily
activity of the New Jersey shipping and receiving
departments and personnel, along with warehouse
and inventory management. Ashmed’s years of
background and experience in accounting and inventory
management, would help him coordinate and further
develop the systems already in place, in his areas
of responsibility. |
|
|
|
|
|
|
| |
Trade
Shows this month |
|
| |
| |
Health
Ingredients Japan 2002,
Tokyo, Oct 9-11, Booth# H-201
Biotech 2002,
Philadelphia, PA, Sept 30-Oct 1, Booth # 42
|
|
|
|
|
|
| |
Product
Ads. |
|
| |
|
|
| |
| Our
Additional Product Websites |
| |
|
|
|
| |
|
|
| |
| "The information
presented in the "Current Issues" Newsletter
from Sabinsa Corporation is for informational purposes
only. It is abstracted from web and print media
sources. Readers are advised to refer to the original
sources for additional information". |
|
|
|
| |
|
|
|
